key: cord-0905171-payq85a9
authors: Jørgensen, Rikke Lind; Pedersen, Martin Schou; Chauhan, Alisha Shazad; Andreasson, Louise Munkholm; Kristiansen, Gitte Qvist; Lisby, Jan Gorm; Rosenstierne, Maiken Worsøe; Schønning, Kristian
title: An in-well direct lysis method for rapid detection of SARS-CoV-2 by real time RT-PCR in eSwab specimens
date: 2021-01-08
journal: J Virol Methods
DOI: 10.1016/j.jviromet.2021.114062
sha: 6a05074ab911d64686f46dd8e3ec3d20e9732da9
doc_id: 905171
cord_uid: payq85a9

BACKGROUND: Diagnostic real time reverse transcription PCR (rRT-PCR) is usually done using nucleic acid (NA) purified from the sample. In the SARS-CoV-2 pandemic reagents and utensils for NA purification has been in short supply. This has generated interest in methods that eliminate the need for NA purification. OBJECTIVES: To investigate if addition of detergent to rRT-PCR master mix (MM) enabled in-well direct lysis and detection of SARS-CoV-2 in clinical eSwab specimens. STUDY DESIGN: IGEPAL-CA-630 (IGEPAL) was added to SARS-CoV-2 MM to 0.3 % final concentration and crude sample was added directly to the PCR well containing MM. Cycle of positivity (Cp) and categorical agreement was compared in samples tested in standard rRT-PCR after NA purification and in in-well lysis, direct rRT-PCR. RESULTS: In-well lysis direct rRT-PCR detected SARS-CoV-2 in 27/30 previously SARS-CoV-2+ samples with an average bias of 3.26 cycles (95 %CI: 0.08–6.43 cycles). All 30 previously test negative samples remained negative when tested in in-well lysis, direct PCR. CONCLUSIONS: Supplementation of detergent to MM was shown to be useful for the detection of SARS CoV-2 in eSwab specimens (COPAN) by direct rRT-PCR without prior NA purification.

Diagnostic PCR assays are usually performed using purified nucleic acid (NA) as template to ensure optimal performance. In the current SARS-CoV-2 pandemic commercial assays are few and limited in supply. To provide sufficient and timely diagnostic capabilities many laboratories have adapted various laboratory developed assays disseminated through the WHO website (whoinhouseassays.pdf [Internet] , 2021) to their available molecular workflows. A key platform component is automated liquid handlers capable of performing NA purification, e.g. MagNA Pure (Roche Diagnostics), Qiagen Symphony (QIAGEN), EMAG (bioMérieux). Supply of dedicated reagents and utensils for these liquid handlers is often less than demand and this has generated an interest for alternative methods for preparing samples for rRT-PCR.

Preparation of a crude lysate for PCR by boiling the sample is a standard technique used in molecular biology (e.g. for colony PCR to screen for recombinants). Heat treatment of swab specimens as preparation for PCR for Herpes Simplex and Varicella Zoster Virus directly on clinical specimens resulted in only marginal loss of analytical sensitivity (Pandori et al., 2006; Buelow et al., 2013; Fan et al., 2014) . Several recent reports (Fomsgaard and Rosenstierne, 2020; Bruce et al., 2020) suggest that swab specimens could be prepared for SARS CoV-2 diagnostics by rRT-PCR by short heat treatment. Heat treatment, however, involves additional manipulation of sample, which increases risk of sample to sample contamination. Direct lysis protocols are sometimes used in cellular gene expression studies. In a comparison study cell lysis using a hypotonic solution of BSA gave results comparable to standard spin column RNA purification (Svec et al., 2013) . Non-ionic detergents sometimes in combination with BSA have been used for direct cellular lysis in preparation of cells for rRT-PCR studies (Eaton et al., 1997; Le et al., 2015; Shatzkes et al., 2014) .

To investigate if addition of detergent to rRT-PCR master mix (MM) enabled in-well direct lysis and detection of SARS-CoV-2 in clinical eSwab specimens.

SARS-CoV-2 testing was done by rRT-PCR targeting the E-gene after purification of total NA (TNA) on a MagNA Pure 96 using the MagNA Pure 96 DNA and Viral NA small volume kit and 190 μl of sample material mixed with 10 μl of sample processing control. TNA was eluted in 100 μl. The primers and probes of the E-gene have previously been published (Corman et al., 2020) , sample processing control was detected in a separate reaction. Final concentrations of E-gene specific primers and probes were 400 nM E_Sarbeco_F primer, 700 nM E_Sarbeco_R For initial experiments direct lysis were performed using the E-gene targeted rRT-PCR described above and differing concentrations of IGE-PAL CA-630 (Sigma-Aldrich) and bovine serum albumin (BSA, Sigma-Aldrich). Then the PCR was transferred to a 96-well format using 5 μL E-swab inoculum in a 50 μL reaction volume and optimized primers and probe concentrations. For FV1S MM the 100 nM E_Sarbeco_F primer, 400 nM E_Sarbeco_R primer, 150 nM E_Sarbeco_P1 probe was used; for Luna Universal Probe One-Step RT-qPCR MM (Luna MM) 100 nM E_Sarbeco_F primer, 700 nM E_Sarbeco_R primer, 200 nM E_Sarbeco_P1 probe was used. PCR cycling conditions were unchanged from the standard SARS-CoV-2 rRT-PCR in 384 well format.

We first titrated IGEPAL (to final concentrations 0 %, 0.2 %, and 0.4 %) and BSA (to final concentrations 0 %, 0.8 %, and 1.6 %) in checkerboard fashion in SARS-CoV-2 rRT-PCR assay directed against the Egene and using FV1S MM using two SARS-CoV-2-positive eSwab specimens. Addition of IGEPAL decreased Cp by 6.1 cycles and 2.2 cycles for sample B and D, respectively ( Fig. 1) with no apparent effect of increasing the concentration of IGEPAL. Only minute, non-directional effects of BSA were observed. Purified TNA from two SARS-CoV-2+ samples were tested again in MM containing 0.0, 0.2, and 0.4 % IGEPAL to investigate if IGEPAL inhibited PCR. Addition of IGEPAL increased average Cp with 0.22/0.27 cycles and 0.13/0.08 cycles at 0.2 % and 0.4 % IGEPAL for the two samples. For further experiments, we decided to use IGEPAL at a final concentration of 0.3 % and not to include BSA.

We next investigated if eSwab medium influenced rRT-PCR. MagNA Pure purified TNA from a SARS-CoV-2-positive sample was diluted in uninoculated eSwab medium to simulate different sample volumes added to the reaction mix using 6 replicates ( Table 1) . Addition of eSwab medium to the reaction mix inhibited rRT-PCR (ANOVA P < 0.001); proportions corresponding to 10 % of reaction volume resulted in a small, but significant 0.17 cycle increase in mean Cp-value further increasing to 2.50 cycles at 36 % of reaction volume. As further inhibition from substances present in directly lysed clinical swab material should be expected, we decided to limit the volume of eSwab sample material to 10 % of reaction volume.

In order to preserve analytical sensitivity, we adapted the SARS-CoV-2 rRT-PCR to a 50 μL reaction volume in a 96 well plate. Using 5 μL of sample eSwab in the direct lysis protocol we analyzed 30 SARS-CoV-2+ samples and 30 SARS-CoV-2-samples. The direct lysis method detected SARS-CoV-2 in 27/30 previously positive samples (sensitivity 0.90; 95 %CI: 0.74− 0.96). The three undetected samples all had Cp >35 in our standard assay. All 30/30 negative samples were also undetected in the direct lysis assay. Samples detected in both assays displayed an average bias in Cp of 3.26 cycles (95 %CI: 0.08-6.43 cycles) (cf. Fig. 2A ). Of note, Cp increased between 0.12 and 8.04 cycles using direct lysis ( Fig. 2A) .

Comparable results were obtained with Luna MM with 27/30 positive samples detected with a larger average bias in Cp of 4.96 (95 %CI: 2.10-7.81) (Fig. 2B) , however, 1/10 previously negative samples was positive with a Cp-value of 38.78. Repeated experiments using the same samples and different sample volumes indicated that the increase in Cp-values was sample specific. To investigate if the Cp increase was caused by inhibitors, we spiked 10 SARS-CoV-2+ and 10 negative samples with Phocine Distemper Virus (PDV) and detected SARS-CoV-2 and PDV in separate reactions. PDV was uniformly detected in all samples (SD: 0.54 cycles) and PDV Cps did not correlate with difference in detection of SARS-CoV-2 after direct lysis and NA purification.

Here we show that a direct in-well lysis method can detect SARS-CoV-2 by rRT-PCR with an estimated 90 % sensitivity and an average loss of 3.3 cycles in Cp compared to automated NA purification prior to rRT-PCR. This is comparable with the reported loss of sensitivity when using heat lysis of samples prior to rRT-PCR (Fomsgaard and Rosenstierne, 2020; Bruce et al., 2020) , but with a simpler workflow. We did not test the direct lysis method with commercial SARS-CoV-2 PCR assays. Previously, it was reported that the RealStar SARS-CoV-2 Assay was susceptible to inhibitors present in crude lysates of clinical swab samples (Fomsgaard and Rosenstierne, 2020) , and direct lysis therefore needs validation with the specific assay employed.

NA purification delivers a larger fraction of original sample to PCR explaining up to 1.6 cycle difference in Cp in our setting. Samples varied in the loss of Cp cycles compared to NA purification. If exogeneous RNA virus was spiked into the sample Cps did not vary arguing against PCR inhibition or RNA degradation. A likely explanation is that in some samples SARS-CoV-2 RNA is less accessible after detergent treatment. Some commercial cell lysis agents include a protease in the lysis step. This may decrease variation between samples, but necessitates an additional step to stop lysis before adding sample to MM. We examined samples collected into eSwabs reflecting our current diagnostic challenge. This transport medium may inhibit rRT-PCR. Dry swabs allow the laboratory to optimize lysis buffer for analytical performance. A recent study reported favorable results eluting dry swabs in Tris-EDTA and directly performing rRT-PCR on the eluate (Srivatsan et al., 2020) . Dry swabs are also amenable to enzymatic lysis buffers that may be inactivated prior to rRT-PCR. However, this flexibility comes at the expense of the in-well workflow described here.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Fig. 2 . Comparison between standard PCR after NA purification and direct, in-well lysis PCR using either FV1S MM (A) or Luna MM (B). Thirty eSwab samples that tested positive in standard PCR was tested again in direct, in-well lysis PCR and the resulting Cps are shown. Samples not detected by direct PCR, but by standard PCR are indicated with red dots and arbitrarily assigned a Cp-value 45. Thirty previously negative samples were also unreactive in direct, in-well lysis PCR using FV1S, however, 1/10 previously negative was reactive when tested in Luna MM. Two different sets of samples were used to obtain the data presented in (A) and (B).

Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step

Comparison of two multiplexed PCR assays for the detection of HSV-1, HSV-2, and VZV with extracted and unextracted cutaneous and mucosal specimens

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells

Clinical validation of the Lyra direct HSV 1+2/VZV assay for simultaneous detection and differentiation of three herpesviruses in cutaneous and mucocutaneous lesions

An alternative workflow for molecular detection of SARS-CoV-2 -escape from the NA extraction kit-shortage

An optimised direct lysis method for gene expression studies on low cell numbers

Real-time PCR for detection of herpes simplex virus without nucleic acid extraction

A simple, inexpensive method for preparing cell lysates suitable for downstream reverse transcription quantitative PCR

Preliminary support for a "dry swab, extraction free" protocol for SARS-CoV-2 testing via RT-qPCR

Direct cell lysis for single-cell gene expression profiling

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.